|
|||||
Biocon CEO Siddharth Mittal outlines the company's strategy in the competitive GLP-1 market. Focusing on liraglutide's launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is actively filing for approvals, anticipating launches in 2027.
Category:
News and Media
The Ark Wildlife Park is home to exotic animals such as crocodiles, monkeys and wildcats.
Category:
News and Media
The comments come after US President Donald Trump said he wants global tariffs to replace income taxes as America's main revenue source.
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||